Skip to main content
. 2021 Sep 24;232:108860. doi: 10.1016/j.clim.2021.108860

Fig. 1-.

Fig. 1-

Local and systemic reaction following the third SARS-CoV-2 BNT162b2 vaccine dose among Immunocompromised individuals a (N = 3195) and Seniors 60 years of age and older (N = 14,625), Maccabi Healthcare Services national survey, Israel, July 20–August 10, 2021. Weights were applied in presenting the distribution calculations of systemic side effects. Chi square test was used, p-values <0.05 were considered statistically significant.

* p < 0.001.

a Solid organ transplants, patients with hematologic malignancies and on immunosuppressive treatment.